Back to Report Store Home

Global Genetic Disorders Drugs Market to 2023 – A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • Published: Dec-2017
  • Report Code: GBIHC464MR
  • Report Format: pdf

Description

List of Tables

Table 1: Genetic Disorders, Common Symptoms of Genetic Disorders 14

Table 2: Genetic Disorders, Affected Areas of LSDs 15

Table 3: Genetic Disorders, Classification of Lysosomal Storage Diseases, 2017, Part 1 23

Table 4: Genetic Disorders, Classification of Lysosomal Storage Diseases, 2017, Part 2 25

Table 5: Genetic Disorders, Global, Epidemiology of Genetic Disorders, 2017 27

Table 6: Genetic Disorders, CF Severity Classification, 2017 33

Table 7: Stages of Duchenne Muscular Dystrophy, 2017 35

Table 8: Genetic Disorders, Global, CF Treatment Plan, 2017 38

Table 9: Genetic Disorders, Global, DMD Treatment Plan, 2017 39

Table 10: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Soliris, 2017 45

Table 11: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Orkambi, 2017 46

Table 12: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Cerezyme, 2017 48

Table 13: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Myozyme/Lumizyme, 2017 50

Table 14: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Fabrazyme, 2017 51

Table 15: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Pulmozyme, 2017 53

Table 16: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Kalydeco, 2017 55

Table 17: Genetic Disorders Market, Global, CFTR Gene Mutations Responsive to Kalydeco, 2017 55

Table 18: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Elaprase, 2017 57

Table 19: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Vimizim, 2017 58

Table 20: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Cerdelga, 2017 60

Table 21: Genetic Disorders Market, Global, Approved Genetic Disorders Indications for Cerdelga, 2017 61

Table 22: Genetic Disorders Market, Global, Annual Revenue Forecast for Key Products ($bn), 2016–2023 94

Table 23: Genetic Disorders Market, Global, Usage of Generics Across Key Indications, 2017 96

Table 24: Genetic Disorders Market, Global, Forecast Revenue by Company, 2016–2023 105

Table 25: Genetic Disorders Market, Global, Licensing Deals, 2006–2017 126

Table 26: Genetic Disorders Market Therapeutics Market, Global, Co-development Deals, 2006–2017 134

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards